Microbial Genomics as a Catalyst for Targeted Antivirulence Therapeutics
Virulence arresting drugs (VAD) are an expanding class of antimicrobial treatment that act to “disarm” rather than kill bacteria. Despite an increasing number of VAD being registered for clinical use, uptake is hampered by the lack of methods that can identify patients who are most likely to benefit...
Main Authors: | Vitali Sintchenko, Verlaine Timms, Eby Sim, Rebecca Rockett, Nathan Bachmann, Matthew O'Sullivan, Ben Marais |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.641260/full |
Similar Items
-
Advances in Clinical Sample Preparation for Identification and Characterization of Bacterial Pathogens Using Metagenomics
by: Nathan L. Bachmann, et al.
Published: (2018-12-01) -
Genome-wide comparison of Corynebacterium diphtheriae isolates from Australia identifies differences in the Pan-genomes between respiratory and cutaneous strains
by: Verlaine J. Timms, et al.
Published: (2018-12-01) -
Editorial: Pathogen Genomics: Empowering Infectious Disease Surveillance and Outbreak Investigations
by: Marc J. Struelens, et al.
Published: (2020-05-01) -
Key Transitions in the Evolution of Rapid and Slow Growing Mycobacteria Identified by Comparative Genomics
by: Nathan L. Bachmann, et al.
Published: (2020-01-01) -
AN INVESTIGATION OF VARIOUS SOURCES OF HEALTH DATA FOR SWINE DISEASE SURVEILLANCE
by: O'Sullivan, Terri Lynne
Published: (2011)